Annual General Meeting of BioGaia
The Annual General Meeting of BioGaia AB (publ) on 5 May 2023 voted, among other things, to approve the following...
Read moreBioGaia AB: Interim Management Statement – January – March 2023
FIRST QUARTER 2023 Figures in parentheses refer to the corresponding period last year, unless otherwise specified. · Net sales amounted to...
Read moreInvitation to media and analyst briefing for BioGaia Q1 2023 report
BioGaia's (NASDAQ: BIOG) financial report for the first quarter of 2023 will be published at approximately 8:00 AM...
Read moreBioGaia launches a probiotic food supplement for women before and during pregnancy
Prenatal Care is a probiotic food supplement that contains BioGaia's patented bacteria strain L. reuteri DSM 17938 along with...
Read moreNotice to attend the Annual General Meeting of BioGaia AB (publ)
BioGaia AB (publ) will hold its Annual General Meeting at 4:00 p.m. on Friday, 5 May 2023, at...
Read moreBioGaia launches probiotic skin ointment for infants and children
For the first time in its over 30-year history, BioGaia is launching its own cosmetic probiotic product, Aldermis. Children’...
Read moreManagement Changes at BioGaia AB
Isabelle Ducellier, Chief Executive Officer has today announced that she has decided to resign from the company and take on...
Read moreBioGaia Annual and Sustainability Report 2022 published
The BioGaia (NASDAQ: BIOG) Annual and Sustainability Report 2022, Remuneration Report 2022 and Corporate Governance Report 2022 in Swedish as...
Read more